| Source: |
| Type: |
| Synergy — Interaction in which two or more agents, treatments, or biological interventions produce a combined effect greater than would be expected from their individual effects. In pharmacology and cancer research, synergy commonly refers to enhanced therapeutic efficacy when a compound is combined with chemotherapy, radiation, targeted therapy, or another bioactive agent. Typical modulation in cancer: ↑ synergy is generally favorable when it increases tumor-cell killing, suppresses proliferation, enhances apoptosis or ferroptosis, or improves sensitivity to anticancer therapy. Synergy should be distinguished from simple additive effects and ideally supported by quantitative combination analysis such as combination index, Bliss independence, Loewe additivity, or related methods. Typical modulation in Alzheimer’s disease: Context-dependent. Synergy may describe enhanced neuroprotective, anti-inflammatory, antioxidant, or cognitive effects produced by combinations of compounds or treatments, but it is not a disease-specific molecular pathway. |
| 7286- | GGB, | Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | PC9 |
| 7260- | Gink, | Ginkgetin: A natural biflavone with versatile pharmacological activities |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 7265- | Gink, | Ginkgetin targets GRP78 to induce dual pathways of ER stress and immune activation in osteosarcoma |
| - | vitro+vivo, | OS, | NA |
| 7306- | GoldNP, | Rad, | Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma |
| - | in-vivo, | SCC, | NA |
| 7320- | Gos, | AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma |
| - | Trial, | Melanoma, | NA |
| 7311- | Gos, | Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials |
| - | Review, | CLL, | NA |
| 7482- | H2, | Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application |
| - | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA | - | Review, | Sepsis, | NA | - | Review, | AD, | NA |
| 2516- | H2, | Hydrogen Gas in Cancer Treatment |
| - | Review, | Var, | NA |
| 2528- | H2, | Local generation of hydrogen for enhanced photothermal therapy |
| - | in-vitro, | Var, | NA |
| 3152- | H2, | VitC, | Rad, | Hydrogen and Vitamin C Combination Therapy: A Novel Method of Radioprotection |
| - | in-vitro, | Nor, | HUVECs | - | in-vivo, | NA, | NA |
| 1627- | HCA, | CRMs, | Sper, | Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance |
| - | Review, | Var, | NA |
| 1628- | HCA, | ALA, | Addition of Hydroxy Citrate improves effect of ALA |
| - | Review, | Var, | NA |
| 7455- | HNK, | Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies |
| - | Review, | Var, | NA |
| 2865- | HNK, | Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma |
| - | in-vitro, | MB, | DAOY | - | vitro+vivo, | NA, | NA |
| 2864- | HNK, | Honokiol: A Review of Its Anticancer Potential and Mechanisms |
| - | Review, | Var, | NA |
| 7574- | HPT, | Oxy, | Improvement of tumor oxygenation by mild hyperthermia |
| - | Review, | Var, | NA |
| 5051- | HPT, | doxoR, | Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells |
| - | in-vitro, | Melanoma, | A375 |
| 7643- | Ins, | IP6, | Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud |
| - | Trial, | BC, | NA |
| 7636- | Ins, | Myo-Inositol: Pharmacokinetics, Biological Functions, and Therapeutic Potential in Liver Protection: Insights from Preclinical Models |
| - | Review, | Nor, | NA |
| 7635- | Ins, | The Role of Inositols in Endocrine and Neuroendocrine Tumors |
| - | Review, | Thyroid, | NA |
| 7631- | Ins, | IP6, | Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate |
| - | Review, | Var, | NA |
| 7672- | iod, | Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study |
| - | Trial, | BC, | NA |
| 7653- | IP, | Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel |
| - | in-vivo, | Var, | NA |
| 7722- | IP6, | Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic |
| - | Review, | Var, | NA |
| 7690- | IP6, | Ins, | Inositol Hexaphosphate (IP6) and Colon Cancer: From Concepts and First Experiments to Clinical Application |
| - | Review, | Colon, | NA |
| 7696- | IP6, | Ins, | The Combination of Inositol Hexaphosphate and Inositol Inhibits Metastasis of Colorectal Cancer Cells by Upregulating Claudin 7 |
| - | vitro+vivo, | Colon, | SW48 | - | in-vitro, | Colon, | SW-620 |
| 9247- | ISO, IH, | capec, | Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer |
| - | vitro+vivo, | GC, | NA |
| 7861- | isoO, | Isoorientin Inhibits Inflammation in Macrophages and Endotoxemia Mice by Regulating Glycogen Synthase Kinase 3 β |
| - | vitro+vivo, | Nor, | RAW264.7 |
| - | in-vitro, | AD, | HT22 |
| 9173- | ITCs, | SFN, | Dietary isothiocyanates and anticancer agents: exploring synergism for improved cancer management |
| - | Review, | Var, | NA |
| 9191- | ITCs, | AITC, | BITC, | PEITC, | SFN | Molecular Targets of Isothiocyanates in Cancer: Recent Advances |
| - | Review, | Var, | NA |
| 9193- | ITCs, | PEITC, | BITC, | SFN, | Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research |
| - | Review, | Var, | NA |
| 7994- | itraC, | From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer |
| - | Review, | Pca, | NA |
| 8033- | IVM, | dietMet, | rMETase, | Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells |
| - | in-vitro, | CRC, | HCT116 |
| 8029- | IVM, | Ivermectin in Cancer Treatment: Should Healthcare Providers Caution or Explore Its Therapeutic Potential? |
| - | Review, | Var, | NA |
| 8026- | IVM, | immuno, | Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer |
| - | vitro+vivo, | BC, | 4T1 |
| 8006- | JG, | VitC, | Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer |
| - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | Bxpc-3 |
| 7962- | JG, | Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide |
| - | in-vitro, | Var, | NA |
| 5115- | JG, | Natural Products to Fight Cancer: A Focus on Juglans regia |
| - | Review, | Var, | NA |
| 8068- | KAE, | TRAIL/rTRAIL, | Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis |
| - | in-vitro, | Colon, | NA |
| 8072- | KAE, | Natural defense against colorectal cancer: the effects of kaempferol on epigenetics, apoptosis, inflammation, oxidative stress, and cell proliferation |
| - | Review, | CRC, | NA |
| 8055- | KAE, | Molecular Mechanisms of the Anticancer Activity of the Flavonoid Kaempferol: A Comprehensive Review |
| - | Review, | Var, | NA |
| 9002- | L-THE, | Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | AML, | K562 |
| 8156- | lamb, | A review on chemistry, source and therapeutic potential of lambertianic acid |
| - | Review, | Var, | NA |
| 8174- | Lap, | Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases |
| - | in-vitro, | Var, | NA |
| 8341- | LDN, | Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy |
| - | Review, | Var, | NA |
| 8277- | LE, | Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: Molecular insights |
| - | Review, | Var, | NA |
| 1790- | LEC, | DHA, | Dietary Crude Lecithin Increases Systemic Availability of Dietary Docosahexaenoic Acid with Combined Intake in Rats |
| - | in-vivo, | Nor, | NA |
| 1795- | LEC, | Chit, | Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene |
| - | in-vivo, | Nor, | NA |
| 6464- | LIN, | 1,8-Cin, | Anti-cancer mechanisms of linalool and 1,8-cineole in non-small cell lung cancer A549 cells |
| - | in-vitro, | NSCLC, | A549 | - | in-vitro, | Nor, | WI38 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1849 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid